1. A method is described for the primary culture of human breast tumour cells on feeder layers of the STO mouse embryo fibroblast cell line. 2. The secretion of the prostaglandins E, and F,, from the cells was measured and the results indicate that the secretion of both prostaglandins was dependent on oestrogen-receptor status, with cells from oestrogen-receptor-positive tumours secreting significantly more prostaglandin than cells from oestrogenreceptor-negative tumours.
INTRODUCTION
It is now well established that tumours can produce greater amounts of prostaglandins (PGs) or PG-like material than the tissues in which they occur [14] . The significance of this increased PG secretion, however, remains obscure and there are conflicting reports as to whether these increased levels of PG correlate with other prognostic factors. Poor prognosis in patients with elevated PG levels was first reported by Bennett et al. [S] , but from further studies by the same authors [3] it now appears that PGs may produce both undesirable 347 and desirable effects in malignant disease, and that elevated levels of PG-like material in tumours are not necessarily bad, whilst low levels are not necessarily good. Correlation between PGs and favourable prognostic indices have been reported by numerous authors [4, , whereas no relationship between PGs and established prognostic factors has been reported by others [lo, 111. It is possible, however, that the above discrepancies are attributable more to the techniques and methodologies used rather than to the actual situation occurring in vivo. The most commonly used biochemical prognostic factors in breast cancer are oestrogen receptor (ER) and progesterone receptor status and it is well established that hormone-dependent human breast cancer is characterized by its requirement for oestrogen [ 121, although the progression to hormone-independence (and subsequent patient mortality) is poorly understood. Primary breast cancer cells are difficult to grow, but in studies using human breast cancer cell lines [13] it has been demonstrated that oestrogen stimulates the growth of the cells, and the suggestion has been made that this role is as a promoter rather than an initiator [14] . The object of the present study was therefore to develop a method for the primary culture of human breast cancer cells for their obvious advantages over cell lines in order to investigate their capacity for PG synthesis and to determine whether this was affected by exogenous oestrogen.
MATERIALS AND METHODS

Tissues
Samples of tumour tissue were obtained from 87 women with early carcinoma of the breast; successful cultures were prepared in 16 premenopausal and 55 postmenopausal cases. In addition, cultures were prepared from 12 benign tumours. The tissues were obtained from the Victoria Infirmary, Glasgow, courtesy of Mr D. Smith, and were transported to the laboratory in chilled containers to be used within 1 h of surgery. The patients were staged clinically (T1-T4) and the tumours were grouped according to size (small <3cm and large >3cm).
Tissue culture
Primary cultures of human breast tumour cells were grown on feeder layers of the STO mouse embryo fibroblast cell line (a gift from Dr C. M. MacDonald, Department of Immunology, University of Strathclyde) as follows. The STO cells were grown in antibiotic-free GMEM medium composed of Glasgow modification of Eagle's medium (GMEM x 10, 45 ml), distilled water (400ml), foetal bovine serum (80 ml), sodium bicarbonate (7.5%, 18.75 ml to yield a final concentration of 18.5 mmol/l) and L-glutamine (2 mmol/l). When the cells reached 70% confluence, they were tested for mycoplasmal infection, the medium replaced by fresh medium containing mitomycin C (10 pg/ml) and the cells incubated for 2 h at 37°C in an atmosphere of O,/CO, (95:5). The cells were then washed, incubated for a further 24h in medium only and finally removed by trypsinization to be added to multi-well plates at a density of 105cells/cm2. After a further 24h incubation in medium only, the cells were ready for use.
The tumour cells were prepared by washing trimmed tissue with Hanks balanced salt solution (HBSS) and chopping the tissue into small pieces (1 mm) in HBSS. The chopped tissue was incubated at 37°C for 36h in Dulbecco's modification of Eagle's medium (DMEM)/Ham's medium (1: 1, 10 ml) containing collagenase (200 units/ml). The epithelial cells remained as small clumps because of the junctional complexes connecting them and these were collected by centrifugation before being resuspended and washed several times with HBSS. When the clumps were cultured, cells migrated radially from them and underwent extensive proliferation. After 3 weeks in culture, the cells were examined by electron microscopy and were found to be in a healthy state with numerous mitochondria, rough endoplasmic reticulum and Golgi apparatus. The presence of desmosomes, tonofilaments and microvilli was a clear indication that the cells bore the important ultrastructural markers characteristic of epithelial cells in uiuo. The subsequent differences in activity between cells from malignant and benign tumours confirmed that the former contained at least a high proportion of malignant cells. The enriched epithelial cells were finally collected by settlement, resuspended in culture medium based on DMEM/Ham's medium (composition below) and transferred to individual culture wells containing STO mouse embryo fibroblast feeder cells. The DMEM/Ham's based culture medium consisted of DMEM (40ml), Ham's F10 medium (40ml), foetal bovine serum (15 ml), sodium bicarbonate (7.5%, 0.5 ml to yield a final concentration of 4.7 mmol/l), L-glutamine (2 mmol/l), penicillin and streptomycin (80 units/ml), insulin (10 pg/ml), epidermal growth factor (10 pg/ml), prolactin (1 pg/ml), hydrocortisone (0.1 pg/ml) and cholera toxin (1 pg/ml). Medium was replaced every 2 days, and after 1 week in culture, appropriate experiments were carried out with or without test substances. All cell cultures were set up in triplicate for 48h at 37°C in a CO, incubator. Control incubations with the STO mouse embryo fibroblast cell line were also set up at the same time. After incubation, medium was collected and rapidly frozen to -20°C to await PG analyses. Total DNA per culture well was assayed by the method of Hill & Whatley Cl5-J.
Analysis of samples
PG analysis was carried out as described previously [9] using an antibody supplied by the Pasteur Institute, Paris, for analysis of ethyl acetateextracted samples, with final separation of bound and free prostaglandin E, (PGE,) being achieved with dextran-charcoal. The precision of the PGE, assay was 3.7% within assays (precision) and 5.2% between assays (reproducibility), and the detection limit was 5pg of PGE,. Values for STO feeder cells were subtracted from values for breast cell cultures to obtain net PG synthesis. ER data were kindly provided by Dr R. E. Leake, University of Glasgow, who also obtained tissue samples at the time of surgery (for the method, see [16] ).
Uptake and release of ['Flarachidonic acid
Breast tumour epithelial cells were grown as above for 1 week and then cultured for 48 h in the presence of [ ''C]arachidonic acid (0.1 pCi). Excess radioactive arachidonic acid was removed from the wells by several washes with balanced salt solution. Cells from three wells were then trypsinized and collected for lipid analysis and DNA assay. Fresh medium (1 ml) containing appropriate test substances (oestradiol, progesterone, indomethacin or calcium ionphore A23187) in triplicate at concentrations of lpg/ml were added to the remaining wells and culture was continued for a further 48 h. Cells were then trypsinized and collected to await lipid and DNA analysis. Separate cultures for STO mouse embryo fibroblast feeder cells were set up as appropriate controls and values obtained from these were subtracted from those of tumour epithelial cell cultures.
Lipids were extracted and separated by t.1.c. using well-established standard techniques involving lipid extraction with chloroform/methanol (2:1), separation of lipids by t.1.c. on Kieselgel G plates with the solvent systems hexane/diethyl ether/formic acid (40: 10: 1, by vol.) for neutral lipids and chloroform/ methanol/25% ammonia/water (60: 35:5:2.5, by vol.) for phospholipids. Individual compounds were located by reference to standards, extracted from the plates and their radioactivity measured in a liquid scintillation counter.
Statistical analysis
Student's two-tailed t-test for independent comparison was used to test for statistical differences in mean values between the various groups. If the criteria for conducting the t-test were not met, then the non-parametric equivalent, the Wilcoxon rank sum test, was applied to the data. In all cases P values less than 0.05 were considered significant.
RESULTS
Basal PG production by the feeder layer
The production of PGE, and prostaglandin F,, (PGF,,) by the STO mouse embryo fibroblast cells was found to be 155+33pg 48h-'pg-l of DNA and 103 k 6 pg 48 h-' pg-of DNA, respectively. These values were reduced to 76% of the control values in the presence of the PG inhibitor indomethacin, demonstrating that minimal PG synthesis de nouo occurred in feeder cells. These mean values were subtracted from the values for PG secretion by the tumour cell cultures.
PG production by tumour cells
Cells isolated from benign tumours had only marginally greater levels of PG activity (Figs. 1 and  2) than the feeder cells. Since the level of PG activity in the cultured malignant cells was considerably greater than in the benign cells, this was taken as indirect evidence that they contained a high proportion of malignant cells. The levels of secretion of PGE, and PGF,, by the cultured breast cancer cells are shown in Figs. 1-4 and it is obvious that PGE, is the major compound secreted. Both menopausal status and tumour size appear to be important factors for PGE, secretion from tumour cells and it can be seen from Fig. 1 that the levels of PGE, secreted by cells from postmenopausal patients (n = 54) were significantly greater ( P < 0.05) than those from premenopausal patients (n = 15), whereas cells from small tumours (n = 3 1) produced significantly more PGE, ( P < 0.05) than those from large tumours (n = 37). The clinical stage of the patients was also an important factor for PGE, synthesis (Fig. 3) , with significantly increased PGE, secretion ( P < 0.05) occurring from tumour cells with advancing stage [T, (n=6) or T, (n=40) versus T, (n=8)]. PGF,, secretion appeared in general to mirror that of PGE,, although the levels secreted were considerably smaller and there were no significant differences with pre-and post-menopausal status (Fig. 2) , tumour size (Fig. 2) or clinical stage (Fig.  4) . There was, however, significantly increased secretion (P<0.03) of both PGE, and PGFza from primary tumour cells of ER-positive (ER +) tumours compared with ER-negative (ER-) tumours (Figs. 1 and 2, respectively) .
That all the above increases were due to PG synthesis de nouo was confirmed by the fact that in the presence of indomethacin the secreted levels of PG were similar to those for STO feeder cells alone (195 versus 155pg 48h-'pg-' of DNA for PGE,). The addition of either oestradiol or progesterone (1 pg/ml) to primary tumour cell cultures appeared to cause an increase in both PGE, and PGF,, secretion from the ER+ tumour cells (Table l) , but only in the case of oestradiol addition to ER+ cells did the results reach significance. Some increased secretion of PG also appeared to occur from cultured cells of the ER-tumours, but in this case the increases did not attain statistical significance (Table  1) . The levels of steroid used were considerably higher than those occurring in uiuo [17] but are of the order commonly used in studies in uitro. (Table 2) , where it could act as a precursor for PG synthesis. The results in Table 2 are reported as the average percentage incorporation into each compound. The addition of oestradiol or progesterone to the [ 14C]arachidonic acid labelled tumour cell cultures stimulated the disappearance of label from the cells (which can be interpreted as release of arachidonic acid, and therefore presumably of PG) significantly ( P < 0.05) from ER+ cultured cells but not significantly from ERcultured cells (Table 3 ). The calcium ionophore A23187, on the other hand, caused a significant release (P<0.03) of arachidonic acid from both ER+ and ER-cultured cells.
Arachidonate metabolism in cultured cells
Confirmation of increased
DISCUSS10 N
Since the initial reports that elevated levels of PGs tended to be associated with a poor prognosis in breast cancer [S] , the majority of studies in this area have been with a view to the use of PG measurements for prognosis. Such studies have mainly involved the measurement of basal levels of PGs in tumour tissue and have yielded conflicting results [1-11, 181.
Interest in the role of PGs in breast cancer arose because they are potent stimulators of bone resorption [ 191 and possess haemodynamic properties [20] . Thus local production of PG by tumours might aid subsequent spread. The recent results of Bennett et al. [3] , however, argue against a role for PGs in bone metastasis and these authors also suggest that insufficient prostacyclin will reach the skeleton to have any effect. On the other hand, Meghji et al. [21] have demonstrated that leukotrienes, also formed from the arachidonate cascade, are very potent bone-resorbing factors in vitro, and it is possible that increased arachidonic acid metabolism in tumours could lead to elevated levels of leukotrienes.
In the present studies we have developed a method for the medium-term growth of breast tumour cells in culture and used these cells to demonstrate increased arachidonic acid metabolism in tumours. The cells obtained were probably a mixture from both the malignant and benign components of the tumours [22] , but the increased. PG activity in the malignant cultures compared with benign cultures suggests that a high proportion of malignant cells were present in our cultures. Our results confirm that there is a correlation between tumour size and synthetic capacity for PG, which is in agreement with the results of Bennett et al. [3] , although the latter authors based their results on three tumour sizes. The present data suggest that tumour cells from small and large tumours have differing capacities for PG synthesis, but one should bear in mind that reported relationships (or their lack) between tumour size and basal PG levels may be influenced by other factors, such as the presence of necrotic tissue, which did not influence the present results. The increased capacity for PG synthesis in postmenopausal women compared with premenopausal women and with clinical stage of the disease is also in general agreement with previously published data [3, 111 and the positive correlation found between PG synthesis and ER status in the cultured cells confirms previous data observed for whole tissues [9] . The principal PG synthesized by the cultured cells was PGE,, which suggests that the similar [ll] or higher [4] basal levels of PGF,, reported to be present in tumour tissues may be due to an active PGE, 9-oxoreductase present in the tissues, as suggested by the latter authors, and known to be present in other reproductive tissues [23] . Oestradiol, but not progesterone, stimulated the secretion of PG from the ER+ cultured cells, although this could be interpreted as being due to an effect on cell growth with consequent increased arachidonic acid metabolism. That increased arachidonic acid metabolism did indeed occur in ER+ cultured tumour cells was demonstrated by the fact that there was a greater uptake of radioactive arachidonic acid into the lipid fraction of the cells. Most of this was into the phospholipid fraction, which acts as a substrate for PG metabolism. The disappearance of label from the cells was interpreted as release of radioactive arachidonic acid, which also occurred to a greater extent from ER+ cell cultures than from ER-cell cultures. Of the steroids oestradiol and progesterone, only the former showed a marginally significant trend to stimulating this loss of label. The calcium ionophore A23187, on the other hand, significantly stimulated the release of arachidonic acid from cultures of both ER+ and ER-tumour tissues. The results of the tracer studies confirm increased metabolism of arachidonic acid by cultured cells from ER+ tumours and the effect of the oestradiol could be interpreted as stimulating the growth of the cells and/or possibly stimulating enzymes such as the phospholipases with consequent increased PG synthesis. The secretion of other arachidonic acid metabolites, such as lipoxygenase products with their potent boneresorbing potential [21] , cannot be excluded.
In conclusion, it is highly probable that PGs are simply one of the locally acting growth hormones triggered among the many known growth factors associated with the progression of human breast tumours [12, 131 mainly under the influence of oestrogen and which include platelet-derived growth factor, epidermal growth factor, transforming growth factor and insulin-like growth factor. Further study is essential to determine the exact role of the eicosanoids in this process.
